Azitra

Recent Finacing

Equity

Recent Raise

$8M

Azitra engineers and screens Staphylococcus epidermidis strains using proteomics and genetic engineering to create topical live biotherapeutics that colonize skin and deliver therapeutic proteins for dermatologic conditions.